GTI-2040 and Capecitabine in Treating Patients With Metastatic Breast Cancer

Clinical trial NCT00068588 · COMPLETED

Trial details

NCT number: NCT00068588
Sponsor: National Cancer Institute (NCI)
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Male Breast Cancer Recurrent Breast Cancer Stage IV Breast Cancer

Start date: 2003-10-01
Primary completion: 2010-03-01
Enrollment: 24

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.